Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis

Fig. 5

Survival curves. A The overall survival (OS) of the HER2-positive gastric cancer patients with a p-Smad2-positive and c-Met positive tumor was significantly poorer (p = 0.030) than that of the patients with a p-Smad2-negative and/or c-Met-negative tumor. B There was no significant difference (p = 0.478) in the OS of the HER2-negative gastric cancer patients with a p-Smad2-positive and c-Met positive tumor and that of the patients with a p-Smad2-negative and/or c-Met-negative tumor

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us